IL22 and rheumatoid arthritis: The frequency of Th22 and Th17 cells in peripheral blood and the levels of IL-22, IL-17 and IFN- γ in plasma were decreased in RA patients who received effective treatment with methotrexate and leflunomide, although significant changes were not observed in patients with nonresponsive RA (96).